Ethical aspects in the use of genetic tests

Referencias bibliográficas

• Beauchamp, T. L. y Childress, J. F. (2019). Principles of Biomedical Ethics. Oxford University Press.
• Bunnik EM, Janssens ACJW, Schermer MHN. (2014). Informed consent in direct-to-consumer personal genome testing: The outline of a model between specific and generic consent. Bioethics, 28 (7), 343-351.
• Clayton EW, Evans BJ, Hazel JW, Rothstein MA. (2019). The law of genetic privacy: applications, implications, and limitations. J law Biosci. 6 (1), 1-36.
• Dheensa S, Fenwick A, Lucassen A. (2016). “Is this knowledge mine and nobody else’s? I don’t feel that.” Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics. 42 (3), 174-179.
• Dinulos MBP, Vallee SE. (2020). The Impact of Direct-to-Consumer Genetic Testing on Patient and Provider. Clinics in Laboratory Medicine, 40 (1), 61-67.
• Earl J. (2019). Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine. Am J Bioeth,19 (6), 7-18.
• Esquerda M, Gabaldon S, Gean E. (2013). Deliberación ética sobre los tests genéticos en niños y adolescentes. Rev Neurol. 57, 237-239.
• Esquerda M, Palau F, Lorenzo D, Cambra FJ, Bofarull M, Cusi V, Grup Interdisciplinar en Bioetica (2021). Ethical questions concerning newborn genetic screening. Clinical Genetics, 99 (1), 93-98.
• Gómez-Vírseda C, de Maeseneer Y, Gastmans C. (2020). Relational autonomy in end-of-life care ethics: a contextualized approach to real-life complexities. BMC Med Ethics, 21 (1), 50.
• Hens K, Lévesque E, Dierickx K (2011). Children and biobanks: a review of the ethical and legal discussion. Hum Genet, 130 (3), 403-413.
• Horton R, Crawford G, Freeman L, Fenwick A, Wright CF, Lucassen A. (2019). Direct-to-consumer genetic testing. BMJ, 367.
• Marleen EJ, Selina CMJ, Karla JL. (2016). International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents. Eur J Hum Genet. 25 (1), 10-16.
• McIntyre N, Popper K. (1983). The critical attitude in medicine: the need for a new ethics. Br Med J (Clin Res Ed) , 287 (6409), 1919-1923.
• Niemiec E, Kalokairinou L, Howard HC. (2017). Current ethical and legal issues in health-related direct-to-consumer genetic testing. In Personalized Medicine, 14 (5), 433-445.
• Pereira R, Oliveira J, Sousa M. (2020). Bioinformatics and Computational Tools for Next-Generation Sequencing Analysis in Clinical Genetics. J Clin Med, 9 (1).
• Petersen LM, Lefferts JA. (2020). Lessons Learned from Direct-to-Consumer Genetic Testing. Clinics in Laboratory Medicine, 40 (1), 83-92.
• Prasad V, Vandross A, Toomey C, Cheung M, Rho J, Quinn S, et al. (2013). A decade of reversal: An analysis of 146 contradicted medical practices. Mayo Clin Proc, 88 (8), 790-798.
• Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, et al. (2006). A new definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns, 15 (2), 77-83.
• Tarling T, Goldenberg A, Ellis A, Show V, Velenosi A, Vercauteren S (2021). Ethical Challenges for Pediatric Biobanks. Biopreservation and biobanking, 19 (2).
• Teare JA, Pricktor M, Kaye J (2021). Reflections on dynamic consent in biomedical research: the story so far. European Journal of Human Genetics, 29, 649-656.
• WHO (World Health Organization) (2022). Genetic testing. Human Genomics in Global Health. Available from: https://www.who.int/genomics/elsi/gentesting/en/